Warfarin, even at doses too low to anti-coagulate, may have powerful cancer-prevention potential. In a 1,256,725 person population-based cohort, researchers observed that warfarin use was associated with a 16% reduced incidence of cancer after adjusting for common variables.

See the source article by following the link below:
Warfarin, even at doses too low to anti-coagulate, may have powerful cancer-prevention potential. In a 1,256,725 person population-based cohort, researchers observed that warfarin use was associated with a 16% reduced incidence of cancer after adjusting for common variables.